|Bid||9.35 x 0|
|Ask||9.43 x 0|
|Day's Range||9.35 - 9.43|
|52 Week Range||7.17 - 10.66|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||15.25|
|Earnings Date||Feb 09, 2023|
|Forward Dividend & Yield||0.75 (8.52%)|
|Ex-Dividend Date||Nov 21, 2022|
|1y Target Est||10.30|
Italian insurer Generali has held informal deal talks with Guggenheim Partners on a range of options including a full acquisition of the U.S. investment firm's asset management business, Bloomberg News reported on Friday, citing sources. The options also include a partnership or a strategic investment in Guggenheim, and are intended to bolster the Italian company's asset management business, the report said. Under a plan unveiled in December, Generali had earmarked up to 3 billion euros ($2.9 billion) for mergers and acquisitions in insurance and asset management businesses, citing possible deals in Europe, Asia and the United States.
A strategic plan for Generali backed by rebel shareholder Francesco Gaetano Caltagirone goes in the right direction by setting up the company for growth, another of the top investors in Italy's biggest insurer was quoted as saying. Leonardo Del Vecchio, the billionaire founder of eyewear giant Luxottica and the third-largest investor in Generali behind Caltagirone, told Bloomberg in an interview that candidates put forward for Generali's board by Caltagirone were "highly competent and well balanced." Construction magnate Caltagirone has challenged the reappointment of Generali Chief Executive Philippe Donnet, by proposing the group's former head of Austria, Luciano Cirina, as an alternative CEO.
Two investors in Generali said on Tuesday they had dissolved a pact they had struck last year to challenge the Italian insurer's top shareholder Mediobanca over the renewal of the board. Delfin, the holding of the Italian billionaire Leonardo del Vecchio, and Fondazione CRT said they ended the pact as of March 27 since the purposes for which they signed it have ceased to exist. Europe's third-largest insurer is at the centre of a shareholder battle that has cast doubt on the reappointment of CEO Philippe Donnet, whose term ends in April.